Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease marked by the accumulation of amyloid-β (Aβ) plaques and neurofibrillary tangles. Aβ oligomers cause synaptic dysfunction early in AD by enhancing long-term depression (LTD; a paradigm for forgetfulness) via metabotropic glutamate receptor (mGluR)-dependent regulation of striatal-enriched tyrosine phosphatase (STEP61). Reelin is a neuromodulator that signals through ApoE (apolipoprotein E) receptors to protect the synapse against Aβ toxicity (Durakoglugil et al., 2009) Reelin signaling is impaired by ApoE4, the most important genetic risk factor for AD, and Aβ-oligomers activate metabotropic glutamate receptors (Renner et al., 2010). We therefore asked whether Reelin might also affect mGluR-LTD. To this end, we induced chemical mGluR-LTD using DHPG (Dihydroxyphenylglycine), a selective mGluR5 agonist. We found that exogenous Reelin reduces the DHPG-induced increase in STEP61, prevents the dephosphorylation of GluA2, and concomitantly blocks mGluR-mediated LTD. By contrast, Reelin deficiency increased expression of Ca2+-permeable GluA2-lacking AMPA receptors along with higher STEP61 levels, resulting in occlusion of DHPG-induced LTD in hippocampal CA1 neurons. We propose a model in which Reelin modulates local protein synthesis as well as AMPA receptor subunit composition through modulation of mGluR-mediated signaling with implications for memory consolidation or neurodegeneration.SIGNIFICANCE STATEMENT Reelin is an important neuromodulator, which in the adult brain controls synaptic plasticity and protects against neurodegeneration. Amyloid-β has been shown to use mGluRs to induce synaptic depression through endocytosis of NMDA and AMPA receptors, a mechanism referred to as LTD, a paradigm of forgetfulness. Our results show that Reelin regulates the phosphatase STEP, which plays an important role in neurodegeneration, as well as the expression of calcium-permeable AMPA receptors, which play a role in memory formation. These data suggest that Reelin uses mGluR LTD pathways to regulate memory formation as well as neurodegeneration.

Highlights

  • Alzheimer’s disease (AD) is a socioeconomic burden of sweeping proportions

  • Ab oligomers cripple the synapses through multiple modes of action and hijack the core neuronal machinery leading to inhibition of long-term potentiation (LTP) and enhancement of long-term depression (LTD), paradigms for learning and memory or forgetfulness, respectively

  • We have shown that Reelin inhibits metabotropic glutamate receptors (mGluRs)-LTD, a type of synaptic plasticity that is exacerbated by Ab in AD mouse models

Read more

Summary

Introduction

Alzheimer’s disease (AD) is a socioeconomic burden of sweeping proportions. Dysregulation of synaptic function occurs in AD before overt clinical manifestation. Reelin regulates the surface expression of both AMPARs (Qiu et al, 2006a; Qiu and Weeber, 2007) and NMDAR (Weeber et al, 2002; Chen et al, 2005; Durakoglugil et al, 2009) and is essential for the NMDAR subunit switch during development (Groc et al, 2007) In this current study, we investigated whether Reelin can modulate mGluR-LTD by either applying exogenous Reelin on wild-type hippocampal slices or by using Reelin-deficient slices and determining STEP61 and AMPAR composition. Our data demonstrate that Reelin, through regulation of local protein synthesis, controls the assembly of AMPAR subunits on the synaptic surface, with implications for memory consolidation and neurodegeneration

Materials and Methods
Findings
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call